Thomas K. Equels

CEO & President at AIM ImmunoTech Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: AIM ImmunoTech Inc., 3 years.

AIM ImmunoTech Inc. Director · CEO & President
3 years · Since 2023

Chief executive roles

AIM ImmunoTech Inc. · CEO & President
Dates unknown

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Nov 11, 2026 AIM ImmunoTech Inc. Open-market purchase +35,000 $0.15 $5,215
Nov 10, 2026 AIM ImmunoTech Inc. Open-market purchase +39,000 $0.14 $5,382
Nov 9, 2026 AIM ImmunoTech Inc. Open-market purchase +31,298 $0.16 $5,070
Nov 6, 2026 AIM ImmunoTech Inc. Open-market purchase +20,299 $0.16 $3,167
Nov 6, 2026 AIM ImmunoTech Inc. Open-market purchase +12,751 $0.16 $2,015
Oct 23, 2026 AIM ImmunoTech Inc. Open-market purchase +31,675 $0.16 $5,068
Oct 22, 2026 AIM ImmunoTech Inc. Open-market purchase +31,250 $0.16 $5,094
Sep 17, 2026 AIM ImmunoTech Inc. Open-market purchase +24,000 $0.21 $5,040
Sep 16, 2026 AIM ImmunoTech Inc. Open-market purchase +11,000 $0.21 $2,310
Sep 15, 2026 AIM ImmunoTech Inc. Open-market purchase +22,000 $0.22 $4,840
Sep 14, 2026 AIM ImmunoTech Inc. Open-market purchase +5,900 $0.22 $1,298
Mar 12, 2026 AIM ImmunoTech Inc. Derivative conversion +25,000 — —
Jun 13, 2025 AIM ImmunoTech Inc. Open-market purchase +107 $7.70 $824
Jun 12, 2025 AIM ImmunoTech Inc. Open-market purchase +103 $8.70 $896
Apr 11, 2025 AIM ImmunoTech Inc. Open-market purchase +1,968,504 $0.03 $59,055

Questions about Thomas K. Equels

What boards is Thomas K. Equels on?

Thomas K. Equels sits on the board of AIM ImmunoTech Inc.

What company is Thomas K. Equels the CEO of?

Thomas K. Equels is CEO & President of AIM ImmunoTech Inc.

How long has Thomas K. Equels served on boards?

Our records show at least 4 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.